Manufacturing & Packaging

Anticipated capacity of GMP facility is 60 million vials per year

Additional equipment to be added to the plant next year

Development project features additional manufacturing suites, expansion of storage capabilities

mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year

Deal provides ten23 with drug product development, biologic manufacturing experience

Agreement prioritizes ways to better distinguish biological manufacturing processes

As companies seek interoperability across their organizations, a joint approach to medical information and local pharmacovigilance may deliver future benefits

Italian facilities will supply EU with up to 85 million doses of Covid jab

Biologics manufacturer to construct new C&GT facility to support expansion

Facility meets cGMP standards for radiopharmaceutical production

CDTMO’s fourth site further expands its support of cell therapy delivery and access

Second NJ location will complement global HQ, offer plasmid DNA and AAV production services

Second Carlsbad location expected to double CDMO’s production capacity

Transaction enhances CDMO’s services when it comes to drug product offerings

Deal is expected to boost manufacturer’s European presence, Aceto executives say

Among areas, financial commitment will power clinical and commercial manufacturing suites

The pandemic has accelerated the adoption of enterprise resource planning in pharma supply chain management, as the recent US rise of one “technology enabler” attests

Company officials predict 500 million vaccine doses per year to be produced via the center, which will offer fill-finish, packaging services

Company officials believe new facility will help meet ongoing demand for temperature-controlled packaging

Manufacturing facility to provide 1.5 million square feet of bioproduction technologies

Recent FDA actions may finally usher in access boost to follow-on biologics in the US

R&D partnership with VaxEquity outlines plan to use saRNA as a go-to therapeutic

The steps pharma manufacturers can take to mitigate transportation costs amid Covid’s supply-chain crunch

Financial commitment expected to expand the development and commercialization pipeline for new medicines

Deal is dependent on FDA approval of Phathom’s vonoprazan compound